Comparison between Aakaar Medical Technologies IPO and Turtle Infratrade IPO.
Aakaar Medical Technologies IPO is a SME Fixed Price IPO proposed to list at NSE SME while Turtle Infratrade IPO is a SME Fixed Price proposed to list at BSE SME.
| Aakaar Medical Technologies IPO | Turtle Infratrade IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Indorient Financial Services Ltd. | Inventure Merchant Banker Services Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Alacrity Securities Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Aakaar Medical Technologies IPO is up to ₹25.64 Cr whereas the issue size of the Turtle Infratrade IPO is up to ₹10.80 Cr. The final issue price of Aakaar Medical Technologies IPO is ₹72.00 per share and of Turtle Infratrade IPO is ₹40.00 per share.
| Aakaar Medical Technologies IPO | Turtle Infratrade IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹68.00 per share | |
| Issue Price (Upper) | ₹72.00 per share | |
| Issue Price (Final) | ₹72.00 per share | ₹40.00 per share |
| Discount (Retail) | ₹0.00 per share | |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 1600 shares | 3000 shares |
| Fresh Issue Size | 35,61,600 shares | 27,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹25.64 Cr | up to ₹10.80 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 35,61,600 shares | 27,00,000 shares |
| Issue Size Total (Amount) | up to ₹25.64 Cr | up to ₹10.80 Cr |
Aakaar Medical Technologies IPO opens on Jun 20, 2025, while Turtle Infratrade IPO opens on . The closing date of Aakaar Medical Technologies IPO and Turtle Infratrade IPO is Jun 24, 2025, and , respectively.
| Aakaar Medical Technologies IPO | Turtle Infratrade IPO | |
|---|---|---|
| Anchor Bid Date | Jun 19, 2025 | |
| Issue Open | Jun 20, 2025 | |
| Issue Close | Jun 24, 2025 | |
| Basis Of Allotment (Tentative) | Jun 25, 2025 | |
| Initiation of Refunds (Tentative) | Jun 26, 2025 | |
| Credit of Share (Tentative) | Jun 26, 2025 | |
| Listing date (Tentative) | Jun 27, 2025 | |
| Anchor Lockin End date 1 | Jul 25, 2025 | |
| Anchor Lockin End date 2 | Sep 23, 2025 |
Aakaar Medical Technologies IPO P/E ratio is 12.43, as compared to Turtle Infratrade IPO P/E ratio of 5.4.
| Aakaar Medical Technologies IPO | Turtle Infratrade IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Aakaar Medical Technologies Limited Financial Information (Restated)Aakaar Medical Technologies Limited's revenue increased by 33% and profit after tax (PAT) rose by 110% between the financial year ending with March 31, 2025 and March 31, 2024.
| Turtle Infratrade Limited Financial Information (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.11 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 67.01 | 73.58 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 12.43 | 5.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹102.04 Cr. | ₹40.88 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 43.89% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.02% | 27.77% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.79 | ₹7.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 33.81% | 43.89% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aakaar Medical Technologies IPO Retail Individual Investors (RII) are offered 12,48,000 shares while in Turtle Infratrade IPO retail investors are offered 12,48,000 shares. Qualified Institutional Buyers (QIB) are offered 7,12,000 shares in Aakaar Medical Technologies IPO and in Turtle Infratrade IPO.
| Aakaar Medical Technologies IPO | Turtle Infratrade IPO | |
|---|---|---|
| Anchor Investor Reserveration | 10,67,200 shares | |
| Market Maker Reserveration | 1,88,800 shares | 1,38,000 shares |
| QIB | 7,12,000 shares | |
| NII | 5,34,400 shares | |
| RII | 12,48,000 shares | |
| Employee | 0 shares | |
| Others | ||
| Total | 35,61,600 shares |
Aakaar Medical Technologies IPO subscribed 2.28x in total, whereas Turtle Infratrade IPO subscribed .
| Aakaar Medical Technologies IPO | Turtle Infratrade IPO | |
|---|---|---|
| QIB (times) | 3.51x | |
| NII (times) | 1.48x | |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.93x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.28x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
